Erik A. Johnson

605 total citations
18 papers, 473 citations indexed

About

Erik A. Johnson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Plant Science. According to data from OpenAlex, Erik A. Johnson has authored 18 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Plant Science. Recurrent topics in Erik A. Johnson's work include Pesticide Exposure and Toxicity (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Mitochondrial Function and Pathology (3 papers). Erik A. Johnson is often cited by papers focused on Pesticide Exposure and Toxicity (7 papers), Neuroscience and Neuropharmacology Research (6 papers) and Mitochondrial Function and Pathology (3 papers). Erik A. Johnson collaborates with scholars based in United States and Hungary. Erik A. Johnson's co-authors include Robert K. Kan, Ronald L. Hayes, Kevin Wang, G. Bruce Pike, Jeremy J. Flint, Michelle Guignet, Claire E. Geddes, José Pineda, Stanislav I. Svetlov and Bradley A. Connor and has published in prestigious journals such as Brain Research, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Erik A. Johnson

17 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik A. Johnson United States 9 182 124 104 95 77 18 473
Xuewu Liu China 14 175 1.0× 237 1.9× 125 1.2× 44 0.5× 104 1.4× 59 653
P. M. Abdul Muneer India 13 220 1.2× 77 0.6× 98 0.9× 153 1.6× 40 0.5× 18 554
Ana Borrajo Spain 13 213 1.2× 109 0.9× 182 1.8× 206 2.2× 45 0.6× 21 701
Kala Venkiteswaran United States 11 134 0.7× 188 1.5× 98 0.9× 40 0.4× 19 0.2× 17 481
Patricia Rodriguez‐Rodriguez Sweden 14 255 1.4× 43 0.3× 102 1.0× 97 1.0× 142 1.8× 21 675
Izaskun Rodal Spain 11 244 1.3× 172 1.4× 144 1.4× 132 1.4× 95 1.2× 13 666
Massimo Barbierato Italy 17 170 0.9× 71 0.6× 82 0.8× 211 2.2× 101 1.3× 28 714
L. Thai United States 8 150 0.8× 65 0.5× 179 1.7× 48 0.5× 59 0.8× 12 468
Sun‐Jung Cho South Korea 12 258 1.4× 90 0.7× 66 0.6× 39 0.4× 149 1.9× 16 529

Countries citing papers authored by Erik A. Johnson

Since Specialization
Citations

This map shows the geographic impact of Erik A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik A. Johnson more than expected).

Fields of papers citing papers by Erik A. Johnson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik A. Johnson. The network helps show where Erik A. Johnson may publish in the future.

Co-authorship network of co-authors of Erik A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Erik A. Johnson. A scholar is included among the top collaborators of Erik A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik A. Johnson. Erik A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Jayakumar, Arumugam R., Renzhi Cai, Wei Sha, et al.. (2025). Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness. International Journal of Molecular Sciences. 26(17). 8516–8516. 1 indexed citations
2.
Leighton, Jessica, et al.. (2024). Neurological manifestations of encephalitic alphaviruses, traumatic brain injuries, and organophosphorus nerve agent exposure. Frontiers in Neuroscience. 18. 1514940–1514940.
3.
Moffett, John R., et al.. (2024). Isoflurane-lipid emulsion injection as an anticonvulsant and neuroprotectant treatment for nerve agent exposure. Frontiers in Pharmacology. 15. 1466351–1466351. 1 indexed citations
4.
Puthillathu, Narayanan, John R. Moffett, Alexandru Korotcov, et al.. (2023). Brief isoflurane administration as an adjunct treatment to control organophosphate-induced convulsions and neuropathology. Frontiers in Pharmacology. 14. 1293280–1293280. 5 indexed citations
5.
Johnson, Erik A., et al.. (2019). Retrograde activation of CB1R by muscarinic receptors protects against central organophosphorus toxicity. Neuropharmacology. 155. 113–120. 8 indexed citations
6.
Cadieux, C. Linn, et al.. (2018). Assessment of mouse strain differences in baseline esterase activities and toxic response to sarin. Toxicology. 410. 10–15. 4 indexed citations
7.
Chachich, Mark E., Cary L. Honnold, Heidi M. Hoard-Fruchey, et al.. (2018). Evaluating mice lacking serum carboxylesterase as a behavioral model for nerve agent intoxication. Toxicology Mechanisms and Methods. 28(8). 563–572. 4 indexed citations
8.
Guignet, Michelle, et al.. (2017). Neuropathological and behavioral sequelae in IL-1R1 and IL-1Ra gene knockout mice after soman (GD) exposure. NeuroToxicology. 63. 43–56. 11 indexed citations
9.
Johnson, Erik A., et al.. (2015). Interleukin-18 expression increases in response to neurovascular damage following soman-induced status epilepticus in rats. Journal of Inflammation. 12(1). 43–43. 20 indexed citations
11.
Johnson, Erik A. & Robert K. Kan. (2010). The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. Journal of Neuroinflammation. 7(1). 40–40. 58 indexed citations
13.
Johnson, Erik A., et al.. (2006). Generation of aberrant forms of DFF40 concurrent with caspase-3 activation during acute and chronic liver injury in rats. Biochemical and Biophysical Research Communications. 350(2). 457–462. 1 indexed citations
14.
Johnson, Erik A., Stanislav I. Svetlov, Kevin Wang, Ronald L. Hayes, & José Pineda. (2005). Cell-specific DNA fragmentation may be attenuated by a survivin-dependent mechanism after traumatic brain injury in rats. Experimental Brain Research. 167(1). 17–26. 30 indexed citations
15.
Johnson, Erik A., Stanislav I. Svetlov, G. Bruce Pike, et al.. (2004). Cell-Specific Upregulation of Survivin after Experimental Traumatic Brain Injury in Rats. Journal of Neurotrauma. 21(9). 1183–1195. 31 indexed citations
16.
Fan, Tao, Shao-Hua Yang, Erik A. Johnson, et al.. (2003). 17β-Estradiol extends ischemic thresholds and exerts neuroprotective effects in cerebral subcortex against transient focal cerebral ischemia in rats. Brain Research. 993(1-2). 10–17. 24 indexed citations
18.
Connor, Bradley A., Erik A. Johnson, & Rosemary Soave. (2001). Reiter Syndrome Following Protracted Symptoms ofCyclosporaInfection. Emerging infectious diseases. 7(3). 453–454. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026